未登录

J

Jiujun Zhu

the affiliated cancer hospital of zhengzhou university and henan cancer hospital

H指数:13

被引数:527

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

(Neo)adjuvant therapy patterns and outcomes in patients with HR+/HER2+ early breast cancer: a real-world study using the national cancer information database in China

新辅助/辅助治疗模式与预后在激素受体阳性/人表皮生长因子受体2阳性早期乳腺癌患者中的表现：一项基于中国国家癌症信息数据库的真实世界研究

Therapeutic Advances in Medical Oncology

IF4.2

2026-06-250

PRE

Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2-, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study

Abemaciclib联合内分泌治疗作为激素受体阳性，HER2-高危早期乳腺癌的辅助治疗: III期随机monarchE研究的5年中国人群分析

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-10-230

OAAI

Treatment Patterns of Neoadjuvant Therapy in Chinese Patients with HRPositive/HER2-Positive Early or Locally Advanced Breast Cancer: A Real-World Study Using NCID Data in 2019-2022

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma

CLINICAL ONCOLOGY

IF3

2023-10-013

PRE

Impact of Marital Status on Prognosis of Patients With Invasive Breast Cancer: A Population-Based Study Using SEER Database

FRONTIERS IN ONCOLOGY

IF3.3

2022-07-2211

OAAI

Pathological response and predictive role of tumour- infiltrating lymphocytes in HER2-positive early breast cancer treated with neoadjuvant pyrotinib plus trastuzumab and chemotherapy (Panphila): a multicentre phase 2 trial

EUROPEAN JOURNAL OF CANCER

IF7.1

2022-04-0132

OA

Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

CHINESE MEDICAL JOURNAL

IF7.3

2021-10-051

OAAI

Essential amino acid metabolism-related molecular classification in triple-negative breast cancer

IF2.6

2021-08-275

PRE

Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-04-2910

OAAI

Clinical practice guidelines for modified radical mastectomy of breast cancer: Chinese Society of Breast Surgery (CSBrs) practice guidelines 2021

CHINESE MEDICAL JOURNAL

IF7.3

2021-04-2010

OAAI

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis

IF3.4

2021-02-067

OAAI

Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients

SCIENTIFIC REPORTS

IF3.9

2021-01-1412

OAAI

Neoadjuvant pyrotinib plus trastuzumab, docetaxel, and carboplatin in patients with HER2-positive early breast cancer: A single-group, multicenter, phase II study

ANNALS OF ONCOLOGY

IF65.4

2020-09-014

OAAI